[The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001161:Arteriosclerosis / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002301:Cardiac Glycosides / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D004357:Drug Synergism; D004562:Electrocardiography; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007511:Ischemia; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D009570:Nitriles / Q000494:pharmacology*; D012216:Rheumatic Diseases / Q000188:drug therapy; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D002301:Cardiac Glycosides; D009570:Nitriles; D014665:Vasodilator Agents; D014700:Verapamil
Die antiarrhythmischen und coronardilatierenden Eigenschaften von Verapamil bei Patienten mit ischämischen Herzkrankheiten.